Cerity Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cerity Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,971	Closed	-$274K	–	1184
2022 Q1	$274K	Sell	5,971 -1,034	-15%	-$49.3K	﹤0.01%	758
2021 Q4	$429K	Buy	7,005 +43	+0.6%	+$2.97K	0.01%	639
2021 Q3	$520K	Buy	6,962 +67	+1%	+$5.62K	0.01%	455
2021 Q2	$638K	Sell	6,895 -910	-12%	-$77.4K	0.01%	428
2021 Q1	$693K	Buy	7,805 +918	+13%	+$91.1K	0.02%	390
2020 Q4	$642K	Buy	+6,887	New	+$549K	0.02%	368

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Cerity Partners's ARKG Position: Q2 2022 in Review

Cerity Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 5,971 shares — an estimated $274K sold.

Cerity Partners first reported a position in ARKG in Q4 2020 and held it in 6 quarters. The position peaked at $693K in Q1 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Cerity Partners reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Cerity Partners sold 5,971 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $274K.
Cerity Partners first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 6 quarters.
Cerity Partners's ARK Genomic Revolution ETF position peaked at $693K in Q1 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Cerity Partners's 13F filing for Q2 2022, filed 10 Aug 2022.